Press Release
Your NEXT Option™Jan / 2023
Grand Opening of joint venture brings access to proprietary Phase I program to more patients
Nov / 2022
Teon Therapeutics Announces First Patient Treated in Phase 1/2 Clinical Trial of TT-816, a Novel Oral Immune Checkpoint Inhibitor, in Patients with Advanced Solid Tumors
Oct / 2022
The Theresa Mays Endowed Merit Award Established for Promising Investigators Holding a PharmD Degree
Oct / 2022
NEXT Oncology Selects proXimityTM to Automate Data Transfer for Clinical Trials
Sep / 2022
NEXT Oncology’s Dr. Anthony Tolcher Presents Data on Well-Tolerated Monotherapy
for Advanced and Metastatic Tumors at ESMO Congress 2022
Jun / 2022
Virginia Cancer Patient “Living with (Stage 4) Cancer” Thanks to Clinical Trial
Request Information From NEXT
We will respond to you with more information soon.Contact NEXT